Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening
Part of paid clinical trials in St Louis, Missouri.
- Sponsor
- Washington University School of Medicine
- Study ID
- NCT07453459
- Status
- Recruiting
Conditions
- Cervical Cancer
- HPV Infection
Eligibility Criteria
- Sex
- FEMALE
- Age
- 25 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- Qualitative Interview — BEHAVIORALParticipants will participate in a semi-structured qualitative interview conducted with a research coordinator and guided by the Capability, Opportunity, Motivation, Behavior model (COM-B).
- Virtual Visit Standard Instructions — BEHAVIORALParticipants will be given information about the self-collection kit along with a QR code they can use to register with Teal and request the telehealth appointment needed to receive their Teal At-Home cervical cancer screening kit.
- Virtual Visit Standard Instructions + In-Person Registration Navigation — BEHAVIORALParticipants will be given information about the self-collection kit along with a QR code they can use to register with Teal and request the telehealth appointment needed to receive their Teal At-Home cervical cancer screening kit. Participants will scan the QR code and complete the registration process onsite with a study coordinator, leaving the event with a scheduled date and time for their telehealth appointment.
Study Details
This study is testing and implementing an equity-focused, community-based intervention that improves women's access to cervical cancer screening and adherence to follow up after an abnormal result. The study's objective is to assess and compare the feasibility of different methods of distributing at-home HPV testing kits for cervical cancer screening among individuals who are under-screened.
Key Dates
- Start date
- Apr 17, 2026
- Status verified
- Apr 2026
- Primary completion
- Nov 15, 2027
- Completion
- Jan 15, 2028
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Active Comparator: Aim 1: Standard instructionsParticipants will complete a sociodemographic questionnaire and will receive the standard instructions. After approximately 8 weeks, participants will be asked to participate in the qualitative interview.
- Experimental: Aim 1: Standard instructions + in-person guidanceParticipants will complete a sociodemographic questionnaire and will receive the standard instructions and in-person navigation for registering for a consult to receive the at-home testing kit. After approximately 8 weeks, participants will be asked to participate in the qualitative interview.
Primary Outcome Measure
Proportion of participants who returned HPV samples [ Time Frame: Up to eight weeks after enrollment ]
Central Contacts
- Michelle Silver, PhD, ScM314-454-7903
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Washington University School of Medicine | St Louis | Missouri | 63110 | Ashley Housten, OTD, MSCI (SUB_INVESTIGATOR) Lindsay Kuroki, MD, MSCI (SUB_INVESTIGATOR) Meera Muthukrishnan, PhD, MPH (SUB_INVESTIGATOR) Trena Depel, VP (SUB_INVESTIGATOR) |
Find similar trials in St Louis, MO
By condition
By specialty
By research site
Related Studies
- Mindfulness in Endometrial and Cervical CancerRecruiting · St. Louis University · St Louis, Missouri
- A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix CancerRecruiting · GOG Foundation · Goodyear, Arizona
- Glutaminase Inhibition and Chemoradiation in Advanced Cervical CancerPHASE2 · Not Yet Recruiting · Washington University School of Medicine · St Louis, Missouri
- A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid TumorsPHASE1 · Recruiting · Genentech, Inc. · San Francisco, California